Results 251 to 260 of about 3,072,312 (306)

Neurocognitive Dysfunction in Fibrosing Interstitial Lung Diseases: A Multidimensional Analysis of Pulmonary, Cognitive, and Clinical Correlates. [PDF]

Diagnostics (Basel)
Vastag Z, Tudorache E, Traila D, Ciortea I, Fira-Mladinescu O, Oancea C, Bratosin F, Rosca EC.   +7 more
europepmc   +1 more source

Intelligent Automation Improved Efficiency in Pharmacovigilance Safety Signal Assessment

Clinical Pharmacology &Therapeutics, EarlyView.
Pharmacovigilance is the science involving the detection, assessment, understanding, and prevention of adverse events associated with drugs, biologics, or medical devices. In pharmacovigilance, information that suggests a new potential causal relationship between an intervention and an adverse event is called a safety signal. Following their detection,
Jeffrey Warner, Luis Henrique De Souza Teodoro, Anaclara Prada Jardim, Claudia Albera   +3 more
wiley   +1 more source

A novel, non-spirometric "BMP index" for predicting severe adverse outcomes in fibrosing interstitial lung diseases. [PDF]

Sci Rep
Huang TH, Hou HY, Chang HY, Hu CH, Kuo HI, Er HP, Wu YW, Lin CY, Tseng YL, Wang JM, Huang LT, Weng CT, Lin SH, Shieh CC, Wu CL.   +14 more
europepmc   +1 more source

The role of transbronchial lung cryobiopsy in multidisciplinary discussion for interstitial lung diseases: a dual-center retrospective study. [PDF]

Ther Adv Respir Dis
Liu Q, Wang T, Chang Q, Xu N, Mao R, Li M, Sun D, Chen Y, Zhang H, Zhang H, Li F.   +10 more
europepmc   +1 more source

Radiation-triggered acute exacerbation of progressive fibrotic interstitial lung diseases: 'Are we advancing the frontier or crossing a dangerous line?' [PDF]

Ther Adv Respir Dis
Dimeas IE, Miziou A, Mitchell PD, Daniil Z, McCarthy C.   +4 more
europepmc   +1 more source

Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases. [PDF]

Tuberc Respir Dis (Seoul)
Park C, Yeo Y, Woo A, Yoo JW, Hong G, Shin JW, Park SW.   +6 more
europepmc   +1 more source

Macrophage subtypes and pathways in autoimmune interstitial lung diseases: potential therapeutic targets. [PDF]

Front Immunol
Tyagi R, Kant S.
europepmc   +1 more source

Quantitative assessment of thoracic morphometry in interstitial lung diseases: a CT-based comparison of nonspecific interstitial pneumonia, usual interstitial pneumonia, and healthy control. [PDF]

Pol J Radiol
Er Ulubaba H, Deniz G.
europepmc   +1 more source

Interstitial lung diseases

Lancet, The, 2022
Over 200 interstitial lung diseases, from ultra rare to relatively common, are recognised. Most interstitial lung diseases are characterised by inflammation or fibrosis within the interstitial space, the primary consequence of which is impaired gas exchange, resulting in breathlessness, diminished exercise tolerance, and decreased quality of life ...
Toby Maher, Marlies Wijsenbeek
exaly   +4 more sources

Lung Microbiome in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases [PDF]

International Journal of Molecular Sciences, 2022
Interstitial lung diseases represent a heterogeneous and wide group of diseases in which factors leading to disease initiation and progression are not fully understood.
Andrea Gramegna, Antonio Voza, Marco Mantero   +2 more
exaly   +4 more sources